GIC to Invest in Bloomage BioTechnology

Singapore’s GIC Private Limited plans to invest HK$ 659 million in Bloomage BioTechnology Corporation Limited, a Chinese medical cosmetic products and services company. The investment comes in two pieces, HK$ 465 million in convertible bonds and HK$ 194 million in new shares. [ Content protected for Sovereign Wealth Fund Institute Standard subscribers only. Please subscribe to view content. ]

Contact the writer or creator of this article or page.
Questions or comments: support(at)swfinstitute(dot)org
Follow on Twitter at @swfinstitute and @sovereignfunds
Learn, Attend and Network: Institutional Investor Events and Summits
Go Back: HOME: Sovereign Wealth Fund Institute
institutional investor investment mandates